In Brief: Ephedrine misuse
This article was originally published in The Tan Sheet
Executive Summary
Ephedrine misuse: AMA will "work on a national level to broaden physician awareness about, and support efforts to reduce, the illicit use of ephedrine as a psychostimulant and as a precursor for methcathinone," the association's House of Delegates agreed during their June 18-22 policy-setting conference in Chicago. Delegates expressed concern about continued use of ephedrine to manufacture street drugs despite FDA and DEA efforts to combat this problem , but also cautioned against restrictions that may be so severe as to limit legitimate uses of the product...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning